Clinical Trial: A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A 4 Week Randomized Double-Blind Parallel Group Active Comparator Controlled Study of Elidel for the Treatment of Seborrheic Dermatitis

Brief Summary: This is an exploratory study to determine effectiveness of Elidel for the treatment of seborrheic dermatitis

Detailed Summary: This is a 4 week study for patients 18 and olderto compare the efficacy and safety of pimecrolimus cream 1% twice daily and ketaconazole cream 2 % twice daily for the treatment of seborrheic dermatitis.
Sponsor: Dermatology Specialists Research

Current Primary Outcome: The change of IGA from BL to wk 1 will be the primary efficacy variable

Original Primary Outcome: Same as current

Current Secondary Outcome: Key secondary efficacy will be the % of patients with facial clearance

Original Secondary Outcome: Same as current

Information By: Dermatology Specialists Research

Dates:
Date Received: November 21, 2006
Date Started: January 2007
Date Completion:
Last Updated: March 31, 2009
Last Verified: October 2007